Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05231 (
interleukin-6
)
23,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Obesity is linked to a low-level chronic inflammatory state that may contribute to the development of associated metabolic complications.
Retinol-binding protein 4
(
RBP4
) is an adipokine associated with parameters of obesity including insulin resistance indices, body mass index, waist circumference, lipid profile, and recently, with circulating inflammatory factors. Due to the infiltration of adipose tissue in obesity by macrophages derived from circulating monocytes and, on the other hand, the existence of a close genetic relationship between adipocytes and macrophages, we decided to examine if
RBP4
is expressed in monocytes and/or primary human macrophages. While we did not detect expression of
RBP4
in undifferentiated monocytes,
RBP4
expression became evident during the differentiation of monocytes into macrophages and was highest in differentiated macrophages. Once we demonstrated the expression of
RBP4
in macrophages, we checked if
RBP4
expression could be regulated by inflammatory stimuli such as tumor necrosis factor-alpha (TNF-alpha),
interleukin-6
(
IL-6
), or the endotoxin lipopolysaccharide (LPS). We observed that while
RBP4
expression was strongly inhibited by TNF-alpha and LPS, it was not affected by
IL-6
. Our results highlight the complexity behind the regulation of this adipokine and demonstrate that
RBP4
expression in macrophages could be modulated by inflammatory stimuli.
...
PMID:Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4). 1953 32